SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,598,000 | +29.3% | 16,334 | -22.1% | 0.58% | +19.1% |
| Q4 2018 | $2,010,000 | -23.1% | 20,979 | +13.4% | 0.49% | +0.2% |
| Q3 2018 | $2,614,000 | +5.5% | 18,507 | +17.0% | 0.49% | +1.5% |
| Q2 2018 | $2,477,000 | -52.4% | 15,823 | -51.0% | 0.48% | -50.5% |
| Q1 2018 | $5,199,000 | +176.8% | 32,278 | +7.1% | 0.97% | +84.9% |
| Q3 2017 | $1,878,000 | -32.5% | 30,144 | -13.7% | 0.52% | -36.4% |
| Q2 2017 | $2,782,000 | +1.3% | 34,936 | -9.6% | 0.82% | +19.7% |
| Q1 2017 | $2,747,000 | – | 38,651 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |